The UCSF Pediatric Immunology Center offers comprehensive evaluations and consultations for children and adolescents with problems involving the immune system.
These include chronic and unusual infections, and primary immunodeficiency disorders, such as hypogammaglobulinemia, which can lead to repeated upper respiratory infections, antibody deficiencies, defects in white blood cells (which play a key role in immune function) and additional immune system impairments. We are a designated center of excellence for immunology care in California.
Our outpatient infusion center provides therapy with intravenous immune globulin and other injected medications.
We have extensive experience in diagnosing and caring for babies and children born with severe combined immunodeficiency (SCID). Our center is designated by the California Department of Public Health to perform screening tests for SCID in newborns, and we can rapidly evaluate babies with abnormal test results. We're also a Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency, one of 125 in the country that receive funding from the Jeffrey Modell Foundation.
Our locations (1)
Alice Y. Chan
MD, PhDPediatric allergist, immunologist and rheumatologist
Morton J. Cowan
MDPediatric immunologist and bone marrow transplant specialist
Jasmeen S. Dara
MD, MSPediatric immunologist and allergist
Morna J. Dorsey
MD, MMSPediatric immunologist and allergist
Jennifer M. Puck
MDPediatric immunologist and allergist
LCSW, MSWSocial worker
PNPPediatric nurse practitioner
Awards & recognition
Ranked among the nation's best in 10 specialties
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Autologous Gene Therapy for Artemis-Deficient SCID
Patient survival status and (if applicable) cause of death will be recorded to assess overall survival.
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (ATHENA)
Our research initiatives
UCSF Division of Allergy, Immunology & BMT Research
Learning never stops